Primary Record
BW-A1433
Note: Only for scientific research or as raw materials for production.
- In stock
- 7,271 g
- Purity
- 98.8 %
- CAS
- 106465-45-6
Compound Identifiers & Properties
- CAS
- 106465-45-6
- PubChem CID
- 6439089
- SMILES
- CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC=C(C=C3)/C=C/C(=O)O
- Canonical SMILES
- CCCn1c(=O)c2[nH]c(-c3ccc(/C=C/C(=O)O)cc3)nc2n(CCC)c1=O
Names & Synonyms
- BW-A1433
- AC1O5QYB
- BWA1433
- RefChem:917775
- CHEMBL16997
- D0O3SA
- BW A1433
- GTPL443
- BWA-1433
- UGCOFEOEBHUEHA-JXMROGBWSA-N
- orb1697992
- SCHEMBL6555021
- BWA 1433
- SCHEMBL30741228
- BDBM85036
- ATL-801
- 1,3-dipropyl-8-(4-acrylate)phenylxanthine
- 106465-45-6
- BDBM50037440
- BW-A-1433
- PDSP1_000308
- PDSP1_000446
- PDSP2_000306
- PDSP2_000444
- AKOS040750955
- C20-H22-N4-O4
- CAS_129447
- CID6439089
- NSC_129447
- (E)-3-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenyl]prop-2-enoic acid
- (E)-4-(1,2,3,6-Tetrahydro-2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)cinnamic acid
- J564.328G
- J622.544F
- LS-123765
- 3-[4-(1,3-Dipropylxanthin-8-yl)phenyl]acrylic acid
- Q27075599
- (E)-3-(4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenyl)-2-propenoic acid
- 121496-66-0
- 2-Propenoic acid, 3-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenyl)-, (E)-
- 4-(1,2,3,6-Tetrahydro-2,6-dioxo-1,3-dipropyl-9H-purin-8-yl)cinnamic acid
- Adenosine A2b receptor antagonists (diabetes), Pennsylvania State University
- (E)-3-(4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenyl)prop-2-enoic acid
- 3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenyl]-acrylic acid
- 3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenyl]prop-2-enoic acid
- (2E)-3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)phenyl]prop-2-enoic acid
- (E)-3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-phenyl]-acrylic acid
- (E)-3-[4-[(1,3-Dipropyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin)-8-yl]phenyl]propenoic acid
- 2-Propenoic acid, 3-(4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)phenyl)-
- Adenosine A2b receptor antagonists (coronary artery occlusion), Pennsylvania State University